287 related articles for article (PubMed ID: 22035869)
1. Cell competition and its implications for development and cancer.
Tamori Y; Deng WM
J Genet Genomics; 2011 Oct; 38(10):483-95. PubMed ID: 22035869
[TBL] [Abstract][Full Text] [Related]
2. dMyc functions downstream of Yorkie to promote the supercompetitive behavior of hippo pathway mutant cells.
Ziosi M; Baena-López LA; Grifoni D; Froldi F; Pession A; Garoia F; Trotta V; Bellosta P; Cavicchi S; Pession A
PLoS Genet; 2010 Sep; 6(9):e1001140. PubMed ID: 20885789
[TBL] [Abstract][Full Text] [Related]
3. Loss of the Drosophila cell polarity regulator Scribbled promotes epithelial tissue overgrowth and cooperation with oncogenic Ras-Raf through impaired Hippo pathway signaling.
Doggett K; Grusche FA; Richardson HE; Brumby AM
BMC Dev Biol; 2011 Sep; 11():57. PubMed ID: 21955824
[TBL] [Abstract][Full Text] [Related]
4. A tumor-suppressing mechanism in Drosophila involving cell competition and the Hippo pathway.
Menéndez J; Pérez-Garijo A; Calleja M; Morata G
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14651-6. PubMed ID: 20679206
[TBL] [Abstract][Full Text] [Related]
5. Xrp1 is a transcription factor required for cell competition-driven elimination of loser cells.
Baillon L; Germani F; Rockel C; Hilchenbach J; Basler K
Sci Rep; 2018 Dec; 8(1):17712. PubMed ID: 30531963
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
Hao Y; Chun A; Cheung K; Rashidi B; Yang X
J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
[TBL] [Abstract][Full Text] [Related]
7. The ligand Sas and its receptor PTP10D drive tumour-suppressive cell competition.
Yamamoto M; Ohsawa S; Kunimasa K; Igaki T
Nature; 2017 Feb; 542(7640):246-250. PubMed ID: 28092921
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Lgl and Mahjong/VprBP in cell competition.
Tamori Y; Bialucha CU; Tian AG; Kajita M; Huang YC; Norman M; Harrison N; Poulton J; Ivanovitch K; Disch L; Liu T; Deng WM; Fujita Y
PLoS Biol; 2010 Jul; 8(7):e1000422. PubMed ID: 20644714
[TBL] [Abstract][Full Text] [Related]
9. The lethal giant larvae tumour suppressor mutation requires dMyc oncoprotein to promote clonal malignancy.
Froldi F; Ziosi M; Garoia F; Pession A; Grzeschik NA; Bellosta P; Strand D; Richardson HE; Pession A; Grifoni D
BMC Biol; 2010 Apr; 8():33. PubMed ID: 20374622
[TBL] [Abstract][Full Text] [Related]
10. Differences in levels of the transmembrane protein Crumbs can influence cell survival at clonal boundaries.
Hafezi Y; Bosch JA; Hariharan IK
Dev Biol; 2012 Aug; 368(2):358-69. PubMed ID: 22683826
[TBL] [Abstract][Full Text] [Related]
11. Akt is negatively regulated by Hippo signaling for growth inhibition in Drosophila.
Ye X; Deng Y; Lai ZC
Dev Biol; 2012 Sep; 369(1):115-23. PubMed ID: 22732571
[TBL] [Abstract][Full Text] [Related]
12. Deciphering tumor-suppressor signaling in flies: genetic link between Scribble/Dlg/Lgl and the Hippo pathways.
Enomoto M; Igaki T
J Genet Genomics; 2011 Oct; 38(10):461-70. PubMed ID: 22035867
[TBL] [Abstract][Full Text] [Related]
13. Epithelial neoplasia in Drosophila entails switch to primitive cell states.
Khan SJ; Bajpai A; Alam MA; Gupta RP; Harsh S; Pandey RK; Goel-Bhattacharya S; Nigam A; Mishra A; Sinha P
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):E2163-72. PubMed ID: 23708122
[TBL] [Abstract][Full Text] [Related]
14. Disease implications of the Hippo/YAP pathway.
Plouffe SW; Hong AW; Guan KL
Trends Mol Med; 2015 Apr; 21(4):212-22. PubMed ID: 25702974
[TBL] [Abstract][Full Text] [Related]
15. Filling out the Hippo pathway.
Saucedo LJ; Edgar BA
Nat Rev Mol Cell Biol; 2007 Aug; 8(8):613-21. PubMed ID: 17622252
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors.
Sun G; Irvine KD
Dev Biol; 2011 Feb; 350(1):139-51. PubMed ID: 21145886
[TBL] [Abstract][Full Text] [Related]
17. The BTB-zinc finger transcription factor abrupt acts as an epithelial oncogene in Drosophila melanogaster through maintaining a progenitor-like cell state.
Turkel N; Sahota VK; Bolden JE; Goulding KR; Doggett K; Willoughby LF; Blanco E; Martin-Blanco E; Corominas M; Ellul J; Aigaki T; Richardson HE; Brumby AM
PLoS Genet; 2013; 9(7):e1003627. PubMed ID: 23874226
[TBL] [Abstract][Full Text] [Related]
18. Cell competition may function either as tumour-suppressing or as tumour-stimulating factor in Drosophila.
Ballesteros-Arias L; Saavedra V; Morata G
Oncogene; 2014 Aug; 33(35):4377-84. PubMed ID: 24096487
[TBL] [Abstract][Full Text] [Related]
19. Context-dependent requirement for dE2F during oncogenic proliferation.
Nicolay BN; Frolov MV
PLoS Genet; 2008 Oct; 4(10):e1000205. PubMed ID: 18833298
[TBL] [Abstract][Full Text] [Related]
20. Regulation of organ size: insights from the Drosophila Hippo signaling pathway.
Kango-Singh M; Singh A
Dev Dyn; 2009 Jul; 238(7):1627-37. PubMed ID: 19517570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
